Post-approval studies (Phase 4)Ended earlyNCT01547728
What this trial is testing
Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
Who this might be right for
Thrombophilia Due to Acquired Antithrombin III Deficiency
Mayo Clinic 42